Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	24.09	56.70	45.69
Graham Fair Price	-34.72	34.07	52.19
PEG	593.18	-0.66	0.10
Price/Book	4.25	2.11	2.03
Price/Cash Flow	499.57	339.60	56.64
Prices/Earnings	155.87	38.61	15.09
Price/Sales	8.07	14.09	13.04
Price/FCF	499.57	339.60	56.64
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-14.30	0.62	0.72
Operating Margin	-22.91	0.17	0.22
ROA	-58.79	< 0.005	0.02
ROE	0.03	0.01	-59.26
ROIC	0.04	0.01	-59.33
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	0.09	-64.51
Dividends QOQ	< 0.005	< 0.005	-56.16
EBIT QOQ	0.63	-0.25	-60.45
EPS QOQ	1.58	-0.58	-63.09
FCF QOQ	0.86	-0.82	-4.10
Revenue QOQ	0.11	-0.03	-75.33
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	398.42	298.61	-25.05
Days Sales Outstanding (DSO)	66.91	68.91	2.98
Inventory Turnover	0.23	0.30	33.43
Debt/Capitalization	0.32	0.32	-0.93
Quick Ratio	0.65	0.66	1.13
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	60.03	61.39	2.27
Cash	2.00	1.92	-4.24
Capex	-0.68	-0.73	-6.96
Free Cash Flow	2.15	0.38	-82.22
Revenue	9.33	9.21	-1.34
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.61	1.66	2.65
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.25	9.56	15.87
Naive Interpretation	Member

06 - Financial Health · Weak

Rating